From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

PsychedeliCare EU uses the European Citizens' Initiative to push psychedelic-assisted therapy into European mental health policy, framing access as a public, evidence-based care issue. The narrative follows a founder's personal turning point after an exploratory psilocybin experience, then links it to existing clinical research and the gap between scientific momentum and real-world access. It also outlines how the campaign was built through citizen outreach, including partnerships, public education, and harm-reduction and legal literacy efforts at cultural festivals, community events, and professional symposia. The piece emphasizes why EU governance is complex for cross-border health policy, why stigma still limits open participation, and why patient testimony is treated as evidence that can shift policy conversations. It notes that the signature campaign is approaching its formal end window in January, while a longer-term “PsychedeliCare 2.0” phase focuses on education, collaboration, and safe, ethical pathways into care systems.